Hepatocellular Carcinoma Liver Cancer


Pass It On: It’s National Liver Cancer Awareness Month (October 10, 2016)

As the month of October brings liver cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the... Continue Reading

Oncology Experts Talk About Surgery, Ablation, Embolization, Radiation Therapy, Chemotherapy, and Clinical Trials for Primary Hepatocellular Carcinoma (Liver Cancer) (April 20, 2012)

In a recent Web Chat on CancerConnect.com, Dr. Boris Kuvshinoff II and Dr. Renuka Iyer, Co-Directors of the Liver and Pancreas Tumor Center at Roswell Park Cancer Institute, presented a review of treatment... Continue Reading

Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer (March 20, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are Co-Directors... Continue Reading

CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer on Treatment Options for Patients with Liver Cancer on March 20, 2012 6 PM EST. (March 5, 2012)

Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver... Continue Reading

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were... Continue Reading

Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% (October 30, 2008)

Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% The risk of the spread of cancer along the path of the needle (needle track... Continue Reading

Genes Outside of Cancer Help Predict Outcomes of Liver Cancer Patients (October 21, 2008)

Genes Outside of Cancer Help Predict Outcomes of Liver Cancer Patients Genes that can be measured directly adjacent to the site of a liver cancer can help predict survival among patients diagnosed with... Continue Reading

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer (August 29, 2008)

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular... Continue Reading

Nexavar® Improves Survival in Advanced Liver Cancer (July 24, 2008)

Nexavar® Improves Survival in Advanced Liver Cancer The targeted agent Nexavar (sorafenib) is associated with improved survival and doubling of the time to cancer progression for patients with advanced... Continue Reading

New Treatment Combination for Bile Duct Cancer May Improve Survival (May 5, 2008)

A recent study indicates that the combination of photodynamic therapy (PDT) and endoscopic retrograde cholangiopancreatiography (ERCP) may improve survival for patients with bile duct cancer. These findings... Continue Reading

Invasive Measures May Improve Outcome for Patients with Liver Cancer (April 16, 2008)

A recent study reveals that a combination of chemoembolization and radiofrequency ablation is more effective than either treatment alone for patients with larger liver tumors. These findings were published... Continue Reading

Sutent® Active in Liver Cancer (April 16, 2008)

Sutent® (sunitinib) reduces the risk of cancer spread and the rate of cancer growth among patients with a form of liver cancer known as hepatocellular carcinoma. These results were presented as a late-breaking... Continue Reading

Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival (April 3, 2008)

Researchers in Hong Kong have reported that screening patients with chronic hepatitis for liver cancer improves liver cancer survival rates and may improve chances for cure. The details of the study were... Continue Reading

Nexavar® Added to Treatment Guidelines for Liver Cancer (March 17, 2008)

Nexavar® Added to Treatment Guidelines for Liver Cancer The drug Nexavar® (sorafenib) has been added to the list of treatment options for patients with liver cancer who are not eligible for a liver transplant.... Continue Reading

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF (January 3, 2008)

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF According to an article recently published in the Journal of the American Medical Association, patients with cirrhosis of... Continue Reading

Updates on the Management of Advanced Hepato-pancreato-biliary Malignancies (October 21, 2007)

Updates on the Management of Advanced Hepato-pancreato-biliary Malignancies: A Report from the 14th European Cancer Conference (ECCO) Introduction The 14th European Cancer Conference of the European Cancer... Continue Reading

Hispanics in the U.S. Have Higher Rates of Liver Cancer (October 9, 2007)

Hispanics in the U.S. Have Higher Rates of Liver Cancer According to results recently published in the Archives of Internal Medicine, Hispanics living in the United States have a high rate of hepatocellular... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS